Immunological parameters as a new lead in the diagnosis of ovarian cancer.

  • Baert T
  • Timmerman D
  • Vergote I
 et al. 
  • 16


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Ovarian cancer is the leading cause of pelvic gynecological cancer death in Europe. Prognosis is poor in women diagnosed at stage III to IV or in case disease recurs. Platin-based chemotherapy and radical surgery have already improved prognosis significantly. Novel strategies in the treatment of ovarian cancer are being searched for. The study of the immune system as a valuable parameter in the development of ovarian cancer has been neglected for a long time. Nevertheless, this is a field in full progression and might open new perspectives in the diagnosis and prognosis of ovarian cancer patients and could lead to a more motivated choice of targeted therapies.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • T Baert

  • D Timmerman

  • I Vergote

  • A Coosemans

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free